°µºÚ±¬ÁÏ

As addiction has soared, drugmakers, distributors and pharmacies profited off opioids. Newly released data details who made the pills, where they were sold, and which communities were hit hardest.

It's about 7 o'clock on a Tuesday morning in June and Ashley McAuliffe is getting her 11-year-old son, Aiden, ready for his last day of school."We've got…

The deal to resolve all U.S. federal investigations and claims is the biggest drug industry settlement so far stemming from the nation's deadly opioid epidemic.

Colorado's lawsuit accusing the maker of OxyContin of fueling and profiting from the opioid epidemic has been expanded to include allegations against…

Many of the industry's biggest companies, such as Johnson & Johnson, are tangled up in litigation. The latest filing was by Insys Therapeutics after a $225-million settlement agreement.

The number of drug overdose deaths in Colorado decreased slightly last year but remains high.The Gazette reports that figures from the state Department of…

The company agreed to make the payments to resolve federal criminal and civil investigations of its marketing practices. Five of its executives were convicted separately for the same practices.

A study looked at who gets prescriptions for buprenorphine, and found that white patients are almost 35 times as likely to get the lifesaving addiction treatment than African Americans.

The federal government accused John Kapoor, the founder of Insys Therapeutics, and his co-defendants of running a nationwide bribery scheme that contributed to the opioid crisis.

According to a new NPR/Ipsos opioid poll, 71% of Americans surveyed also say the government should do more to curb the epidemic.